Bayesian Models Leveraging Bioactivity and Cytotoxicity Information for Drug Discovery

Identification of unique leads represents a significant challenge in drug discovery. This hurdle is magnified in neglected diseases such as tuberculosis. We have leveraged public high-throughput screening (HTS) data, to experimentally validate virtual screening approach employing Bayesian models bui...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ekins, Sean, Reynolds, Robert C., Kim, Hiyun, Koo, Mi-Sun, Ekonomidis, Marilyn, Talaue, Meliza, Paget, Steve D., Woolhiser, Lisa K., Lenaerts, Anne J., Bunin, Barry A., Connell, Nancy, Freundlich, Joel S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607962/
https://ncbi.nlm.nih.gov/pubmed/23521795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2013.01.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller